The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
XORTX Therapeutics(NASDAQ:XRTX)


XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, hypertension, insulin resistance, and diabetic nephropathy. It develops XRx-008, a late clinical stage program therapy for autosomal dominant pol...
XORTX Therapeutics Op Cashflow Per Share ttm
XORTX Therapeutics Free Cashflow Per Share ttm
XORTX Therapeutics Cash Per Share ttm
XORTX Therapeutics (GAAP) P/E ratio ttm
XORTX Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.